Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione | Patent Number 07968569

US 07968569 B2
Application Number10438213
Publication NumberUS 20040029832 A1
Pendency8 years, 1 month, 16 days
Filled DateMay 15, 2003
Priority DateMay 17, 2002
Publication DateFeb 12, 2004
Expiration DateMay 17, 2022
Inventor/ApplicantsJerome B. Zeldis
Jerome B. Zeldis
ExaminesSIMMONS, CHRIS E
Art Unit1612
Technology Center1600
Assignments
Celgene
Current
CelgeneBristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.